Member Info for AVCT

"The 6103 dosing news is going to melt your short-circuits."

Problem is NFT this isn't news as everbody expects this in mid feb

2nd fact 15th Jan isn't news either - as CLN doesn't comes back into play until July

And for a hatrick of actual facts we don't have a confirmed date for submission of IND - strong implication it was on or before 31st Dec. No need to make next week a hostage to fortune

I'm relaxed on Avacta science, deals and possibly raises are going to be just fine - but all this noise keeping fud alive is just boring and somewhat annoying

Just helps the traders

GLA investors

"How good a deal can FAP-DOX/SGC command?"

Who says we're dealing on 6k ?

"Fact is I don't believe those accelerated call options for repayments will prove to be a problem"

Imo the best person to opine on what I believe is myself

I'm confused Pedrol - which parts of this don't you agree with

"Fact is accelerated options for heights have also been created"

Please do pist the full rns

Ah how sweet

Thanks Pedral you've just flagged yourself :)

Hi NFT

I broadly agree with the principles ofyour posts - but do think you'd be better served by presenting facts more accurately:

"• The Deferral: Repayments for Jan 20, 2026, and April 20, 2026, have been officially deferred to October 20, 2027."

Fact is accelerated options for heights have also been created

Fact is I don't believe those accelerated call options for repayments will prove to be a problem

Hi Rich

Missing a brain or maybe a heart?

This looks like Motley cràp to me

DYOR

Should have read

@Icecool

At the right price and at the right time

@Icecool

At the right price and at the right price

I think you meant securing next 16 months

Which would be plenty of time to see us through the real crunch negotiation next year

Failing that back up would be real money on Nasdaq

All imo

Too late

I think you've seen the last raise now - earlier today

After hours RNS

Could you help elaborate on these deals you have referenced in your 1st November post - I'm having trouble finding their history and detail

Thanks

"Commercial opportunities include a $3.5-7 billion partnership deal, potentially announced shortly after, with upfront payments of $700 million-£1 billion supported by recent oncology deal precedents like Pfizer's $1.05 billion for Seagen, Merck's $680 million for Acceleron, Bristol-Myers Squibb's $1.25 billion for Mirati, and Roche's $750 million for Regor."

Anyone happen to know the equivalent IG rates?

Still plenty of other purely scientific news this month

7100 candidate selection, 6103 ind approval for example

We have about 6 months in hand for deal announcements - not necessary to time these with these particular scientific news items imo

".....Decent volume.."

Actually post placing volume has now dried up for the time being

We'll break out of 75p when the next little frisson fires up - doesn't really matter exactly when that is

Maybe maybe not

Capped royalty loan agreements are continually evolving and imo a trend for consideration of earlier drug candidates

A trend I feel potentially accelerated by new owners KKR

Time will tell

We'll take SGC into P2 ourselves imo - maybe with HCRx funding

Will know soon either way

"3. this combo in clinic approx 1 year from now."

Errrr listen again I think you mean 2 years - thats good though

"Although CC again talked about the ongoing discussion and some of the. Waiting for "this" data."

Yes that's right and we all know who they are - happy days